Human T-cell Lymphotropic- I-associated Leukemia/

[1]  M. Baba,et al.  Production of functionally deficient dendritic cells from HTLV-I-infected monocytes: implications for the dendritic cell defect in adult T cell leukemia. , 2000, Virology.

[2]  R. Gartenhaus,et al.  Retinoic acid modulates a bimodal effect on cell cycle progression in human adult T-cell leukemia cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  C. Tei,et al.  NF-κB involvement in the activation of primary adult T-cell leukemia cells and its clinical implications , 1999 .

[4]  A. Manns,et al.  Human T-lymphotropic virus type I infection , 1999, The Lancet.

[5]  Shinsuke Suzuki,et al.  Arsenic trioxide inhibits growth of human T‐cell leukaemia virus type I infected T‐cell lines more effectively than retinoic acids , 1998, British journal of haematology.

[6]  D. Spiegelman,et al.  Risk factors for adult T-cell leukemia among carriers of human T-lymphotropic virus type I. , 1998, Blood.

[7]  W. Blattner,et al.  Human leukocyte antigen class II alleles associated with human T-cell lymphotropic virus type I infection and adult T-cell leukemia/lymphoma in a Black population. , 1998, Journal of the National Cancer Institute.

[8]  G. Mufti,et al.  MANAGEMENT OF ADULT T‐CELL LEUKAEMIA/LYMPHOMA , 1998, British journal of haematology.

[9]  M. Tomonaga,et al.  Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. , 1997, Blood.

[10]  A. Iavarone,et al.  Transcriptional activation of the human p21(WAF1/CIP1) gene by retinoic acid receptor. Correlation with retinoid induction of U937 cell differentiation. , 1996, The Journal of biological chemistry.

[11]  J. Tosswill,et al.  Successful treatment of HTLV‐1‐associated acute adult T‐cell leukaemia lymphoma by allogeneic bone marrow transplantation , 1996, British journal of haematology.

[12]  W. Heneine,et al.  Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. The Retrovirus Epidemiology Donor Study Group. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[13]  M. Tomonaga,et al.  An intensive chemotherapy of adult T-cell leukemia/lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[14]  Y. Ville,et al.  Mother-to-child transmission of human T-cell lymphotropic virus types I and II (HTLV-I/II) in Gabon: a prospective follow-up of 4 years. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[15]  M. Yoshida,et al.  HTLV‐1 Tax protein interacts with cyclin‐dependent kinase inhibitor p16INK4A and counteracts its inhibitory activity towards CDK4. , 1996, The EMBO journal.

[16]  T. Waldmann,et al.  Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with Yttrium-90-labeled anti-Tac. , 1995, Blood.

[17]  G. Franchini.  Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. , 1995, Blood.

[18]  S. Peter,et al.  Hypercalcemia associated with adult T-cell leukemia/lymphoma (ATL). , 1995, Journal of the National Medical Association.

[19]  M. Kaplan,et al.  Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. , 1995, The New England journal of medicine.

[20]  E. Macintyre,et al.  Treatment of Adult T-Cell Leukemia-Lymphoma with Zidovudine and Interferon Alfa , 1995 .

[21]  J. Giesecke.  HTLV screening of Swedish blood donors , 1995, The Lancet.

[22]  M. Yoshida,et al.  Human T-cell leukemia virus type-1 (HTLV-1) Tax is expressed at the same level in infected cells of HTLV-1-associated myelopathy or tropical spastic paraparesis patients as in asymptomatic carriers but at a lower level in adult T-cell leukemia cells. , 1995, Blood.

[23]  H. Taguchi,et al.  TRANSMISSION OF HUMAN T‐LYMPHOTROPHIC VIRUS TYPE 1 BY BONE MARROW TRANSPLANTATION , 1995, British journal of haematology.

[24]  M. Matsuoka,et al.  A novel diagnostic method of adult T-cell leukemia: monoclonal integration of human T-cell lymphotropic virus type I provirus DNA detected by inverse polymerase chain reaction , 1994 .

[25]  K. Ikeda,et al.  Development of a sensitive two-site immunoradiometric assay for parathyroid hormone-related peptide: evidence for elevated levels in plasma from patients with adult T-cell leukemia/lymphoma and B-cell lymphoma. , 1994, The Journal of clinical endocrinology and metabolism.

[26]  G. Gahrton,et al.  Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV‐I) following allogeneic bone marrow transplantation for HTLV‐I positive adult T‐cell leukaemia , 1994, British journal of haematology.

[27]  Y. Ohashi,et al.  Treatment of adult T-cell leukaemia-lymphoma with irinotecan hydrochloride (CPT-11). CPT-11 Study Group on Hematological Malignancy. , 1994, British Journal of Cancer.

[28]  M. Tomonaga,et al.  Significance of soluble interleukin‐2 receptor levels for evaluation of the progression of adult T‐cell leukemia , 1994, Cancer.

[29]  K. Yamaguchi,et al.  Human T-lymphotropic virus type I in Japan , 1994, The Lancet.

[30]  A. Dalgleish.  Human T cell leukaemia/lymphoma virus and blood donation. , 1993, BMJ.

[31]  R. Tedder,et al.  Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. , 1993, BMJ.

[32]  K. Akashi,et al.  Hematopoietic progenitor cells from patients with adult T-cell leukemia-lymphoma are not infected with human T-cell leukemia virus type 1. , 1993, Blood.

[33]  J. Brady,et al.  Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotropic virus type I Tax1: evidence for the involvement of transcription factor Ets1 , 1993, Journal of virology.

[34]  E. Ogata,et al.  Interleukin-2 increases production and secretion of parathyroid hormone-related peptide by human T cell leukemia virus type I-infected T cells: possible role in hypercalcemia associated with adult T cell leukemia. , 1993, Endocrinology.

[35]  J. Sparano,et al.  Infusional cyclophosphamide, doxorubicin, and etoposide in human immunodeficiency virus- and human T-cell leukemia virus type I-related non-Hodgkin's lymphoma: a highly active regimen , 1993 .

[36]  G. de Thé,et al.  An HTLV-I vaccine: why, how, for whom? , 1993, AIDS research and human retroviruses.

[37]  R. Ohno,et al.  Treatment of adult T‐cell leukemia/lymphoma with MST‐16, a new oral antitumor drug and a derivative of bis(2,6‐dioxopiperazine) , 1993 .

[38]  C. Rosen,et al.  Cell-type-specific transactivation of the parathyroid hormone-related protein gene promoter by the human T-cell leukemia virus type I (HTLV-I) tax and HTLV-II tax proteins. , 1993, Blood.

[39]  K. Tsukasaki,et al.  Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma. , 1993, Leukemia research.

[40]  E. Ogata,et al.  Transcription of the gene for parathyroid hormone-related peptide from the human is activated through a cAMP-dependent pathway by prostaglandin E1 in HTLV-I-infected T cells. , 1993, The Journal of biological chemistry.

[41]  S. Kamihira,et al.  Phenotypic diversity and prognosis of adult T-cell leukemia. , 1992, Leukemia research.

[42]  G. Mufti,et al.  BEAM regimen and G-CSF in HTLV-I-associated T-cell lymphoma , 1992, The Lancet.

[43]  B. Hanchard,et al.  Childhood infective dermatitis evolving into adult T-cell leukaemia after 17 years , 1991, The Lancet.

[44]  M. Shimoyama,et al.  Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.

[45]  K. Kimura,et al.  A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T‐cell leukemia–lymphoma , 1991, Cancer.

[46]  M. Tomonaga,et al.  Prognostic significance of the proportion of Ki‐67‐positive cells in adult t‐cell leukemia , 1991, Cancer.

[47]  H. Taguchi,et al.  Immunosuppression by HTLV-I infection , 1991, The Lancet.

[48]  K. Uozumi,et al.  Expression of P-glycoprotein in adult T-cell leukemia cells. , 1990, Blood.

[49]  K. Yamaguchi,et al.  Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene , 1990, The Journal of experimental medicine.

[50]  J. Coste,et al.  HTLV-I/II antibodies in French blood donors , 1990, The Lancet.

[51]  E. Ogata,et al.  Parathyroid hormone-related protein in adult T-cell leukemia-lymphoma. , 1989, Annals of internal medicine.

[52]  Chieh-Yu Liu,et al.  Infection of human T-cell leukemia virus type I and development of human T-cell leukemia lymphoma in patients with hematologic neoplasms: a possible linkage to blood transfusion , 1989 .

[53]  J. Sodroski,et al.  Transformation to continuous growth of primary human T lymphocytes by human T-cell leukemia virus type I X-region genes transduced by a Herpesvirus saimiri vector. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[54]  G. Mufti,et al.  Hyperinfection with strongyloides after treatment for adult T cell leukaemia-lymphoma in an African immigrant. , 1988, BMJ.

[55]  S. Tsugane,et al.  Major prognostic factors of adult patients with advanced T-cell lymphoma/leukemia. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[56]  B. Cheson,et al.  2′‐deoxycoformycin therapy in adult T‐cell leukemia/lymphoma , 1987, Cancer.

[57]  T. Imamura,et al.  Recombinant interferon beta and gamma in the treatment of adult T‐cell leukemia , 1987, Cancer.

[58]  W. Blattner,et al.  Non-Hodgkin lymphoma in Jamaica and its relation to adult T-cell leukemia-lymphoma. , 1987, Annals of internal medicine.

[59]  P. Bunn,et al.  Calcitriol levels in hypercalcemic patients with adult T-cell lymphoma. , 1986, Archives of internal medicine.

[60]  Y. Shibata,et al.  BLOOD TRANSFUSION AND HTLV-I ASSOCIATED MYELOPATHY , 1986, The Lancet.

[61]  A. Dalgleish,et al.  T-LYMPHOMA ASSOCIATED WITH HTLV-I OUTSIDE THE CARIBBEAN AND JAPAN , 1985, The Lancet.

[62]  Yasuaki Yamada,et al.  Preleukemic state of adult T cell leukemia: abnormal T lymphocytosis induced by human adult T cell leukemia-lymphoma virus , 1985 .

[63]  K. Yamaguchi,et al.  Variation in the clinical courses of adult T‐cell leukemia , 1985, Cancer.

[64]  W. Blattner,et al.  Clinical course of retrovirus-associated adult T-cell lymphoma in the United States. , 1983, The New England journal of medicine.

[65]  M. Hayami,et al.  VERTICAL TRANSMISSION OF ADULT T-CELL LEUKAEMIA VIRUS , 1983, The Lancet.

[66]  John D. Minna,et al.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma , 1980, Proceedings of the National Academy of Sciences.

[67]  J. Yodoi,et al.  Adult T-cell leukemia: clinical and hematologic features of 16 cases. , 1977, Blood.

[68]  R. Mahieux,et al.  Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples. , 2000, Blood.

[69]  S. Iida,et al.  Microsatellite instability as a potential marker for poor prognosis in adult T cell leukemia/lymphoma. , 1999, Leukemia & lymphoma.

[70]  W. Mckenna,et al.  A novel chemotherapeutic regimen (interferon alfa, zidovudine, and etretinate) for adult T-cell lymphoma resulting in rapid tumor destruction. , 1999, Journal of the American Academy of Dermatology.

[71]  G. de Thé,et al.  An HTLV-I/II vaccine: from animal models to clinical trials? , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[72]  A. Bazarbachi,et al.  Treatment with a combination of zidovudine and alpha-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[73]  B. Hanchard.  Adult T-cell leukemia/lymphoma in Jamaica: 1986-1995. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[74]  M. Essex,et al.  Human T cell leukemia virus type I (HTLV-I) molecular genotypes and disease outcome. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[75]  A. Cereseto,et al.  Insights on the pathogenicity of human T-lymphotropic/leukemia virus types I and II. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[76]  M. Matsuoka,et al.  Adult T-cell leukemia in Japan. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[77]  G. Taylor.  The epidemiology of HTLV-I in Europe. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[78]  N. Mueller,et al.  Findings from the Miyazaki Cohort Study. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[79]  M. Yoshida.  Molecular biology of HTLV-I: recent progress. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[80]  E. Ogata,et al.  Parathyroid hormone-related peptide in hypercalcemia associated with adult T cell leukemia/lymphoma: molecular and cellular mechanism of parathyroid hormone-related peptide overexpression in HTLV-I-infected T cells. , 1995, Mineral and electrolyte metabolism.

[81]  T. Waldmann,et al.  The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotrophic virus I-induced adult T-cell leukemia. , 1993, Blood.

[82]  K. Yamaguchi,et al.  Serum deoxythymidine kinase in adult T-cell leukemia-lymphoma and its related disorders. , 1991, Leukemia research.

[83]  K. Yamaguchi,et al.  Clinical consequences of 2'-deoxycoformycin treatment in patients with refractory adult T-cell leukaemia. , 1986, Leukemia research.